Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 427

1.

NLR-Dependent Regulation of Inflammation in Multiple Sclerosis- Dependent Regulation of Inflammation in Multiple Sclerosis.

Gharagozloo M, Gris KV, Mahvelati T, Amrani A, Lukens JR, Gris D.

Front Immunol. 2018 Jan 18;8:2012. doi: 10.3389/fimmu.2017.02012. eCollection 2017. Review.

2.

Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.

Kim S, Bielawski J, Yang H, Kong Y, Zhou B, Li J.

Glia. 2018 Mar;66(3):654-669. doi: 10.1002/glia.23272. Epub 2017 Nov 29.

PMID:
29193293
3.

The chronically inflamed central nervous system provides niches for long-lived plasma cells.

Pollok K, Mothes R, Ulbricht C, Liebheit A, Gerken JD, Uhlmann S, Paul F, Niesner R, Radbruch H, Hauser AE.

Acta Neuropathol Commun. 2017 Nov 25;5(1):88. doi: 10.1186/s40478-017-0487-8.

4.

Experimental autoimmune encephalomyelitis from a tissue energy perspective.

Desai RA, Smith KJ.

F1000Res. 2017 Nov 8;6:1973. doi: 10.12688/f1000research.11839.1. eCollection 2017. Review.

5.

Strain differences in cuprizone induced demyelination.

Yu Q, Hui R, Park J, Huang Y, Kusnecov AW, Dreyfus CF, Zhou R.

Cell Biosci. 2017 Nov 3;7:59. doi: 10.1186/s13578-017-0181-3. eCollection 2017.

6.

Suppression of Inflammatory Demyelinaton and Axon Degeneration through Inhibiting Kv3 Channels.

Jukkola P, Gu Y, Lovett-Racke AE, Gu C.

Front Mol Neurosci. 2017 Oct 26;10:344. doi: 10.3389/fnmol.2017.00344. eCollection 2017.

7.

Protective effects of erythropoietin against cuprizone-induced oxidative stress and demyelination in the mouse corpus callosum.

Kashani IR, Chavoshi H, Pasbakhsh P, Hassani M, Omidi A, Mahmoudi R, Beyer C, Zendedel A.

Iran J Basic Med Sci. 2017 Aug;20(8):886-893. doi: 10.22038/IJBMS.2017.9110.

8.

B-cell-targeted therapies in relapsing forms of MS.

Dubey D, Forsthuber T, Flanagan EP, Pittock SJ, Stüve O.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 23;4(6):e405. doi: 10.1212/NXI.0000000000000405. eCollection 2017 Nov. Review.

9.

Molecular-based diagnosis of multiple sclerosis and its progressive stage.

Barbour C, Kosa P, Komori M, Tanigawa M, Masvekar R, Wu T, Johnson K, Douvaras P, Fossati V, Herbst R, Wang Y, Tan K, Greenwood M, Bielekova B.

Ann Neurol. 2017 Nov;82(5):795-812. doi: 10.1002/ana.25083.

PMID:
29059494
10.

TNFR1 inhibition with a Nanobody protects against EAE development in mice.

Steeland S, Van Ryckeghem S, Van Imschoot G, De Rycke R, Toussaint W, Vanhoutte L, Vanhove C, De Vos F, Vandenbroucke RE, Libert C.

Sci Rep. 2017 Oct 20;7(1):13646. doi: 10.1038/s41598-017-13984-y.

11.

Splitting the "Unsplittable": Dissecting Resident and Infiltrating Macrophages in Experimental Autoimmune Encephalomyelitis.

Koeniger T, Kuerten S.

Int J Mol Sci. 2017 Sep 29;18(10). pii: E2072. doi: 10.3390/ijms18102072. Review.

12.

Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.

Lehmann-Horn K, Kinzel S, Weber MS.

Int J Mol Sci. 2017 Sep 23;18(10). pii: E2048. doi: 10.3390/ijms18102048. Review.

13.

Host genetic background influences diverse neurological responses to viral infection in mice.

Brinkmeyer-Langford CL, Rech R, Amstalden K, Kochan KJ, Hillhouse AE, Young C, Welsh CJ, Threadgill DW.

Sci Rep. 2017 Sep 22;7(1):12194. doi: 10.1038/s41598-017-12477-2.

14.

Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation.

Madsen PM, Pinto M, Patel S, McCarthy S, Gao H, Taherian M, Karmally S, Pereira CV, Dvoriantchikova G, Ivanov D, Tanaka KF, Moraes CT, Brambilla R.

J Neurosci. 2017 Oct 18;37(42):10185-10199. doi: 10.1523/JNEUROSCI.1378-17.2017. Epub 2017 Sep 20.

PMID:
28931570
15.

The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation.

Hashimoto M, Yamamoto S, Iwasa K, Yamashina K, Ishikawa M, Maruyama K, Bosetti F, Yoshikawa K.

Brain Res Bull. 2017 Oct;135:47-52. doi: 10.1016/j.brainresbull.2017.09.007. Epub 2017 Sep 15.

PMID:
28923306
16.

The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.

Pardo G, Jones DE.

J Neurol. 2017 Dec;264(12):2351-2374. doi: 10.1007/s00415-017-8594-9. Epub 2017 Sep 6. Review. Erratum in: J Neurol. 2017 Dec;264(12 ):2375-2377.

17.

Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production.

Blonda M, Amoruso A, Grasso R, Di Francescantonio V, Avolio C.

Front Neurol. 2017 Aug 22;8:422. doi: 10.3389/fneur.2017.00422. eCollection 2017.

18.

CNS inflammation and neurodegeneration.

Chitnis T, Weiner HL.

J Clin Invest. 2017 Oct 2;127(10):3577-3587. doi: 10.1172/JCI90609. Epub 2017 Sep 5.

19.

Neonatal Lipopolysaccharide Infection Causes Demyelination and Behavioral Deficits in Adult and Senile Rat Brain.

Singh K, Patro N, Pradeepa M, Patro I.

Ann Neurosci. 2017 Jul;24(3):146-154. doi: 10.1159/000477152. Epub 2017 Jul 24.

20.

Enhanced Fluorine-19 MRI Sensitivity using a Cryogenic Radiofrequency Probe: Technical Developments and Ex Vivo Demonstration in a Mouse Model of Neuroinflammation.

Waiczies S, Millward JM, Starke L, Delgado PR, Huelnhagen T, Prinz C, Marek D, Wecker D, Wissmann R, Koch SP, Boehm-Sturm P, Waiczies H, Niendorf T, Pohlmann A.

Sci Rep. 2017 Aug 29;7(1):9808. doi: 10.1038/s41598-017-09622-2.

Supplemental Content

Support Center